Cost-effectiveness of sevelamer versus calcium carbonate plus atorvastatin to reduce LDL in patients with chronic renal insufficiency with dyslipidemia and hyperphosphatemia. [electronic resource]
Producer: 20010108Description: 950-7 p. digitalISSN:- 0277-0008
- Atorvastatin
- Calcium Carbonate -- economics
- Cost-Benefit Analysis
- Decision Support Techniques
- Epoxy Compounds -- economics
- Health Care Costs
- Heptanoic Acids -- economics
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- economics
- Hyperlipidemias -- blood
- Hypolipidemic Agents -- economics
- Kidney Failure, Chronic -- blood
- Lipoproteins, LDL -- blood
- Phosphates -- blood
- Polyamines
- Polyethylenes -- economics
- Pyrroles -- economics
- Sevelamer
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.